Cargando…
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium
OBJECTIVES: It is essential to understand the molecular basis of ovarian cancer etiology and tumor development to provide more effective preventive and therapeutic approaches to reduce mortality. Particularly, the molecular targets and pathways involved in early malignant transformation are still no...
Autores principales: | Zhang, Lifang, Wang, Dan, Jiang, Wei, Edwards, Dale, Qiu, Weiliang, Barroilhet, Lisa M, Rho, Jung-hyun, Jin, Lianjin, Seethappan, Vanitha, Vitonis, Allison, Wang, Jianliu, Mok, Samuel C, Crum, Christopher, Cramer, Daniel W, Ye, Bin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903602/ https://www.ncbi.nlm.nih.gov/pubmed/20576130 http://dx.doi.org/10.1186/1477-7827-8-74 |
Ejemplares similares
-
Spontaneous live recurrent ectopic pregnancy after ipsilateral partial salpingectomy leading to tubal rupture
por: Abraham, Cynthia, et al.
Publicado: (2014) -
Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019) -
αvβ5 Integrin/FAK/PGC-1α Pathway Confers Protective Effects on Retinal Pigment Epithelium
por: Roggia, Murilo F., et al.
Publicado: (2015) -
FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity
por: Timbrell, Simon, et al.
Publicado: (2021) -
Synergism of FAK and ROS1 inhibitors in the treatment of CDH1-deficient cancers mediated by FAK-YAP signaling
por: Gao, Jiaming, et al.
Publicado: (2023)